{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:10:50Z","timestamp":1791544250838,"version":"4.3.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81971271"],"award-info":[{"award-number":["81971271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Bipolar disorder (BD) is a chronic and disabling psychiatric disorder. The treatment of BD still remains a significant clinical challenge due to the complex nature of the disease. Nutraceutical therapy as adjunctive role is a promising therapy for BD. Sulforaphane (SFN), a broccoli extract, was reported to be effective for emotional problems and cognitive impairment. However, clinical research of SFN in the treatment of BD was rare. Therefore, this study is designed to evaluate the adjuvant role of SFN in the treatment of BD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This is a randomized, double-blinded, placebo-controlled, parallel-group clinical trial. A total of 100 patients who meet inclusion criteria will be assigned to receive quetiapine plus SFN or quetiapine plus placebo in a 1:1 ratio. The total duration of the study will be 12 weeks including 5 follow ups. The primary outcome is in the Montgomery\u2013Asberg depression rating scale. The secondary outcomes are the quick inventory of depressive symptomatology\u2014self report, Hamilton anxiety rating scale, young mania rating scale, cognitive function, inflammatory factors, and intestinal flora. Any adverse events will be recorded throughout the trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>This trial will provide evidences to evaluate the efficacy and safety of SFN combined with quetiapine in the treatment of BD patients, as well as the adjuvant role of SFN in combination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>This study protocol was registered at the Chinese clinical trial registry (ChiCTR2000028706).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000020981","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T14:42:34Z","timestamp":1592923354000},"page":"e20981","source":"Crossref","is-referenced-by-count":7,"title":["The efficacy and safety of sulforaphane as an adjuvant in the treatment of bipolar depressive disorder"],"prefix":"10.1097","volume":"99","author":[{"given":"Congchong","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Psychiatry, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyang","family":"Chen","sequence":"additional","affiliation":[{"name":"Taizhou Second People's Hospital, Taizhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou"},{"name":"The Key Laboratory of Mental Disorder Management of Zhejiang Province"},{"name":"Brain Research Institute of Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou"},{"name":"The Key Laboratory of Mental Disorder Management of Zhejiang Province"},{"name":"Brain Research Institute of Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou"},{"name":"The Key Laboratory of Mental Disorder Management of Zhejiang Province"},{"name":"Brain Research Institute of Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tins.2017.10.006","article-title":"The emerging neurobiology of bipolar disorder","volume":"41","author":"Harrison","year":"2018","journal-title":"Trends Neurosci"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12264-018-0301-z","article-title":"Association of genetic polymorphisms with age at onset in Han Chinese patients with bipolar disorder","volume":"35","author":"Hu","year":"2019","journal-title":"Neurosci Bull"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.drudis.2014.07.010","article-title":"Bipolar disorder: recent clinical trials and emerging therapies for depressive episodes and maintenance treatment","volume":"19","author":"Garay","year":"2014","journal-title":"Drug Discov Today"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/DDDT.S63779","article-title":"Quetiapine for acute bipolar depression: a systematic review and meta-analysis","volume":"8","author":"Suttajit","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1017\/S1461145709991246","article-title":"Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: systematic review and meta-analysis","volume":"13","author":"Tamayo","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4088\/JCP.08m04995gre","article-title":"Double-blind, placebo-controlled study (EMBOLDEN I) of quietapine and lithium monotherapy in adults in the acute phase of bipolar depression","volume":"71","author":"Young","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hup.2257","article-title":"Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics","volume":"27","author":"Centorrino","year":"2012","journal-title":"Hum Psychopharmacol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrg3240","article-title":"Genetic architectures of psychiatric disorders: the emerging picture and its implications","volume":"13","author":"Sullivan","year":"2012","journal-title":"Nat Rev Genet"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"6986983","DOI":"10.1155\/2017\/6986983","article-title":"Effect of hypoxic injury in mood disorder","volume":"2017","author":"Zhao","year":"2017","journal-title":"Neural Plast"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2016.07.010","article-title":"Brain-derived neurotrophic factor in mood disorders and antidepressant treatments","volume":"97","author":"Castren","year":"2017","journal-title":"Neurobiol Dis"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S1461145703003407","article-title":"Neuroendocrine profiles in mood disorders","volume":"6","author":"Linkowski","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11920-014-0541-1","article-title":"Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites","volume":"17","author":"Anderson","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fpsyt.2018.00739","article-title":"Microglia and immune system\u2014how are they linked in affective disorder?","volume":"9","author":"Culmsee","year":"2019","journal-title":"Front Psychiatry"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1046\/j.1471-4159.2001.00628.x","article-title":"Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex","volume":"79","author":"Bezchlibnyk","year":"2001","journal-title":"J Neurochem"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1089\/ars.2014.6097","article-title":"Dietary sulforaphane in cancer chemoprevention: the role of epigenetic regulation and HDAC inhibition","volume":"22","author":"Tortorella","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tifs.2017.02.002","article-title":"KEAP1 and done? Targeting the NRF2 pathway with sulforaphane","volume":"69","author":"Dinkova-Kostova","year":"2017","journal-title":"Trends Food Sci Technol"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"1600766","DOI":"10.1002\/mnfr.201600766","article-title":"Stabilized sulforaphane for clinical use: phytochemical delivery efficiency","volume":"61","author":"Fahey","year":"2017","journal-title":"Mol Nutr Food Res"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3389\/fphar.2018.01536","article-title":"Contribution of Nrf2 modulation to the mechanism of action of analgesic and anti-inflammatory drugs in pre-clinical and clinical stages","volume":"9","author":"Staurengo-Ferrari","year":"2018","journal-title":"Front Pharmacol"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00406-017-0848-0","article-title":"Keap1- Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress","volume":"268","author":"Zhang","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13229-018-0218-4","article-title":"Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli","volume":"9","author":"Bent","year":"2018","journal-title":"Mol Autism"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"15550","DOI":"10.1073\/pnas.1416940111","article-title":"Sulforaphane treatment of autism spectrum disorder (ASD)","volume":"111","author":"Singh","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"62","DOI":"10.9758\/cpn.2015.13.1.62","article-title":"An open study of sulforaphane-rich broccoli sprout extract in patients with schizophrenia","volume":"13","author":"Shiina","year":"2015","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jnutbio.2016.10.004","article-title":"Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation","volume":"39","author":"Zhang","year":"2017","journal-title":"J Nutri Biochem"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3389\/fphar.2018.01332","article-title":"Sulforaphane inhibited the nociceptive responses, anxiety- and depressive-like behaviors associated with neuropathic pain and improved the anti-allodynic effects of morphine in mice","volume":"9","author":"Ferreira-Chamorro","year":"2018","journal-title":"Front Pharmacol"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbr.2015.12.030","article-title":"Sulforaphane produces antidepressant- and anxiolytic-like effects in adult mice","volume":"301","author":"Wu","year":"2016","journal-title":"Behav Brain Res"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2147\/NDT.S41081","article-title":"Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study","volume":"9","author":"Jeong","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bdi.12601","article-title":"An update on adjunctive treatment options for bipolar disorder","volume":"20","author":"Dean","year":"2018","journal-title":"Bipolar Disord"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3389\/fphar.2018.00887","article-title":"Role of Keap1-Nrf2 signaling in anhedonia symptoms in a rat model of chronic neuropathic pain: improvement with sulforaphane","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T20:22:26Z","timestamp":1694809346000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020981"}},"subtitle":["Study protocol for a randomized, double-blinded, placebo-controlled, parallel-group clinical trial"],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":30,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020981","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]}}}